Sigma alliance exceeding PharmX’s expectations

PharmX reports “significant strategic and commercial progress” in March 2026 quarter  Pharmacy ordering platform, PharmX, is forecasting its annualised gross transaction value (GTV) will grow to more than $100 million within the next 12 months, following a strong third quarter of the 2026 financial year.   In an update to the Australian Securities Exchange (ASX) the company’s chief executive,